{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:55:28Z","timestamp":1773924928530,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T00:00:00Z","timestamp":1559088000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.biopha.2019.109038","type":"journal-article","created":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T11:27:26Z","timestamp":1559906846000},"page":"109038","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Behavioural effects of inhalation exposure to dizocilpine (MK-801) in mice"],"prefix":"10.1016","volume":"117","author":[{"given":"Hiroshi","family":"Ueno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Suemitsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenta","family":"Wani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoi","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2019.109038_bib0005","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/468158a","article-title":"Schizophrenia: the drug deadlock","volume":"468","author":"Abbott","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2019.109038_bib0010","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.nbd.2013.05.002","article-title":"CNS drug development in Europe--past progress and future challenges","volume":"61","author":"Nutt","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.biopha.2019.109038_bib0015","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","article-title":"Drug transport across the blood-brain barrier","volume":"32","author":"Pardridge","year":"2012","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.biopha.2019.109038_bib0020","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3109\/10717544.2012.752421","article-title":"Novel surface modified solid lipid nanoparticles as intranasal carriers for ropinirole hydrochloride: application of factorial design approach","volume":"20","author":"Pardeshi","year":"2013","journal-title":"Drug Deliv."},{"key":"10.1016\/j.biopha.2019.109038_bib0025","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/head.12186","article-title":"Breath powered nasal delivery: a new route to rapid headache relief","volume":"53","author":"Djupesland","year":"2013","journal-title":"Headache"},{"key":"10.1016\/j.biopha.2019.109038_bib0030","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jconrel.2017.09.001","article-title":"Progress in brain targeting drug delivery system by nasal route","volume":"268","author":"Khan","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2019.109038_bib0035","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jconrel.2016.07.001","article-title":"A review of intranasal formulations for the treatment of seizure emergencies","volume":"237","author":"Kapoor","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2019.109038_bib0040","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ejpb.2015.08.008","article-title":"Intranasal microemulsion for targeted nose to brain delivery in neurocysticercosis: role of docosahexaenoic acid","volume":"96","author":"Shinde","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.biopha.2019.109038_bib0045","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/lary.5541030415","article-title":"Resistance to respiratory airflow of the extrapulmonary airways","volume":"103","author":"Cole","year":"1993","journal-title":"Laryngoscope"},{"key":"10.1016\/j.biopha.2019.109038_bib0050","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrd2153","article-title":"Inhaling medicines: delivering drugs to the body through the lungs","volume":"6","author":"Patton","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2019.109038_bib0055","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/BF02253532","article-title":"Effects of dopamine D1 and D2 receptor blockade on MK-801-induced hyperlocomotion in rats","volume":"111","author":"Ouagazzal","year":"1993","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.biopha.2019.109038_bib0060","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/sj.npp.1380103","article-title":"Phencyclidine- and dizocilpine-induced hyperlocomotion are differentially mediated","volume":"11","author":"Ogren","year":"1994","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopha.2019.109038_bib0065","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1196\/annals.1300.065","article-title":"Glutamatergic animal models of schizophrenia","volume":"1003","author":"Moghaddam","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.biopha.2019.109038_bib0070","first-page":"75","article-title":"Acute administration of MK-801 in an animal model of psychosis in rats interferes with cognitively demanding forms of behavioral flexibility on a rotating arena","volume":"9","author":"Svoboda","year":"2015","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.biopha.2019.109038_bib0075","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1002\/ar.22942","article-title":"White matter injuries induced by MK-801 in a mouse model of schizophrenia based on NMDA antagonism","volume":"297","author":"Xiu","year":"2014","journal-title":"Anat. Rec. (Hoboken)"},{"key":"10.1016\/j.biopha.2019.109038_bib0080","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s12035-017-0715-z","article-title":"Short-term exposure to enriched environment in adult rats restores MK-801-Induced cognitive deficits and GABAergic interneuron immunoreactivity loss","volume":"55","author":"Murueta-Goyena","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2019.109038_bib0085","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pnpbp.2013.11.008","article-title":"Predictive validity of a MK-801-induced cognitive impairment model in mice: implications on the potential limitations and challenges of modeling cognitive impairment associated with schizophrenia preclinically","volume":"49","author":"Brown","year":"2014","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.biopha.2019.109038_bib0090","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0022-3565(24)37870-X","article-title":"Effects of 5-hydroxytryptamine2 receptor antagonism on the behavioral activation and immediate early gene expression induced by dizocilpine","volume":"287","author":"O\u2019Neill","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2019.109038_bib0095","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1017\/S1461145708009085","article-title":"Clozapine reverses schizophrenia-related behaviours in the metabotropic glutamate receptor 5 knockout mouse: association with N-methyl-D-aspartic acid receptor up-regulation","volume":"12","author":"Gray","year":"2009","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.biopha.2019.109038_bib0100","doi-asserted-by":"crossref","first-page":"e778","DOI":"10.1038\/tp.2016.44","article-title":"Knockout of NMDA-receptors from parvalbumin interneurons sensitizes to schizophrenia-related deficits induced by MK-801","volume":"6","author":"Bygrave","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.biopha.2019.109038_bib0105","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.biopha.2018.10.073","article-title":"Anti-depressive-like effect of 2-phenylethanol inhalation in mice","volume":"111","author":"Ueno","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2019.109038_bib0110","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/0091-3057(89)90496-6","article-title":"Pentobarbital-induced hyperactivity in mice: negligible role of opioid mechanisms","volume":"33","author":"Vetulani","year":"1989","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.biopha.2019.109038_bib0115","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0091-3057(87)90555-7","article-title":"Effects of scopolamine on locomotor activity and metabolic rate in mice","volume":"26","author":"Bushnell","year":"1987","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.biopha.2019.109038_bib0120","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/BF00464583","article-title":"Scopolamine-induced locomotor stimulation in mice: effect of diazepam and a benzodiazepine antagonist","volume":"77","author":"Sansone","year":"1982","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.biopha.2019.109038_bib0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-4328(02)00272-3","article-title":"Glutamate receptor function in learning and memory","volume":"140","author":"Riedel","year":"2003","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.biopha.2019.109038_bib0130","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.bbr.2011.10.052","article-title":"Consequences of early life MK-801 administration: long-term behavioural effects and relevance to schizophrenia research","volume":"227","author":"Lim","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.biopha.2019.109038_bib0135","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00008877-199308000-00017","article-title":"Behavioral sensitization to MK-801 (dizocilpine): neurochemical and electrophysiological correlates in the mesoaccumbens dopamine system","volume":"4","author":"Wolf","year":"1993","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.biopha.2019.109038_bib0140","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.1523\/JNEUROSCI.21-12-04451.2001","article-title":"Morphine-induced dependence and sensitization are altered in mice deficient in AMPA-type glutamate receptor-A subunits","volume":"21","author":"Vekovischeva","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2019.109038_bib0145","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0022-3565(24)35047-5","article-title":"Characterization of MK-801-induced behavior as a putative rat model of psychosis","volume":"290","author":"Andin\u00e9","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2019.109038_bib0150","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/08997659.2014.945047","article-title":"Dose-dependent effects of the clinical anesthetic isoflurane on Octopus vulgaris: a contribution to cephalopod welfare","volume":"26","author":"Polese","year":"2014","journal-title":"J. Aquat. Anim. Health"},{"key":"10.1016\/j.biopha.2019.109038_bib0155","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1213\/ANE.0000000000001754","article-title":"Time- and dose-dependent effects of desflurane in sensitized airways","volume":"124","author":"Zhou","year":"2017","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.biopha.2019.109038_bib0160","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.lfs.2017.12.025","article-title":"Mechanism of intranasal drug delivery directly to the brain","volume":"195","author":"Crowe","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2019.109038_bib0165","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1021\/acs.molpharmaceut.5b00402","article-title":"Brain targeting of a water insoluble antipsychotic drug haloperidol via the intranasal route using PAMAM dendrimer","volume":"12","author":"Katare","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biopha.2019.109038_bib0170","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.neuroscience.2008.01.013","article-title":"Delivery of interferon-beta to the monkey nervous system following intranasal administration","volume":"152","author":"Thorne","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopha.2019.109038_bib0175","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1002\/jps.21604","article-title":"Intranasal drug targeting of hypocretin-1 (orexin-A) to the central nervous system","volume":"98","author":"Dhuria","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2019.109038_bib0180","first-page":"139","article-title":"A comparative study of pharmacodynamics and bioavailability of 2 different desmopressin nasal sprays","volume":"36","author":"Eller","year":"1998","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2019.109038_bib0185","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0168-3659(02)00363-2","article-title":"Nasal drug delivery--possibilities, problems and solutions","volume":"87","author":"Illum","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2019.109038_bib0190","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jconrel.2016.07.001","article-title":"A review of intranasal formulations for the treatment of seizure emergencies","volume":"237","author":"Kapoor","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2019.109038_bib0195","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ejpb.2015.08.008","article-title":"Intranasal microemulsion for targeted nose to brain delivery in neurocysticercosis: role of docosahexaenoic acid","volume":"96","author":"Shinde","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.biopha.2019.109038_bib0200","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.teln.2008.04.005","article-title":"Effects of aroma inhalation on examination anxiety","volume":"3","author":"Kutlu","year":"2008","journal-title":"Teach. Learn Nurs."},{"key":"10.1016\/j.biopha.2019.109038_bib0205","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev.physiol.010908.163209","article-title":"Sensing odorants and pheromones with chemosensory receptors","volume":"71","author":"Touhara","year":"2009","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.biopha.2019.109038_bib0210","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/ics.12096","article-title":"Physiological effect of olfactory stimuli inhalation in humans: an overview","volume":"36","author":"Angelucci","year":"2014","journal-title":"Int. J. Cosmet. Sci."},{"key":"10.1016\/j.biopha.2019.109038_bib0215","doi-asserted-by":"crossref","first-page":"6254","DOI":"10.1002\/anie.200600782","article-title":"On the unpredictability of odor","volume":"45","author":"Sell","year":"2006","journal-title":"Angew. Chem. Int. Ed. Engl."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332219322280?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332219322280?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T09:11:35Z","timestamp":1773911495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332219322280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":43,"alternative-id":["S0753332219322280"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2019.109038","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Behavioural effects of inhalation exposure to dizocilpine (MK-801) in mice","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2019.109038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"109038"}}